[Psychological features of patients with bronchial asthma during long-term basic therapy at the "Asthma School"].
OBJECTIVE
To evaluate changes in psychological status of bronchial asthma (BA) patients in the course of the basic treatment (BT) and attending "Asthma-school".


METHODS
107 patients with BA were observed for 2 years. 26 of them had BA stage II (group 1), 54 had stage III (group 2) and stage IV was in 27 patients (group 3). The criteria of PQBI (personal questionnaire of the Bekhterev Institute) and MMPI (Minnesota Multiphasic Personality Inventory) were used. Also, clinical symptoms and external respiration (ER) were studied.


RESULTS
2 years of treatment led to a decline in clinical symptoms (p < 0.001) and ER (p < 0.05) in patients of groups 1 and 2. Their attitude to the disease and treatment has also improved in many cases (p < 0.05). In all the groups the number of patients with neurotic reaction decreased (p < 0.05). In group 3, more patients had sensitive and egocentric reactions (p < 0.05).


CONCLUSIONS
BT and studies in "Asthma-school" brought about harmonic changes in personality and attenuation of neurotic disorders without application of routine psychotherapeutic methods.
Leshchenko
I V
IV
Kuznetsova
E I
EI
Medvedskiĭ
E A
EA
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000336:Aerosols; D000368:Aged; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000523:psychology*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D004205:Cromolyn Sodium / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D005280:Fenoterol / Q000627:therapeutic use; D006801:Humans; D009241:Ipratropium / Q000627:therapeutic use; D008950:MMPI; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000209:etiology; D011795:Surveys and Questionnaires; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000336:Aerosols; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents; D004338:Drug Combinations; C030809:fenoterol, ipratropium drug combination; D005280:Fenoterol; D009241:Ipratropium; D004205:Cromolyn Sodium